Browse by category

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform upcoming guidelines on the use of these drugs to treat obesity. The reviews, which examine the effects of three weight loss drugs known as GLP-1 receptor antagonists, have found that all three drugs result in clinically meaningful weight loss compared w

Liraglutide has been found to lower brain fluid pressure cutting monthly migraine days by more than half, according to a new study,...

Adjunctive use of liraglutide at a dose of 3mg/day with conversional Roux-en-Y Gastric Bypass (cRYGB) results in significant weight loss,...

The outcomes from a pilot randomised controlled trial have revealed that the addition of the GLP-1 agonist receptor liraglutide after...

Researchers at the Max Planck Institute for Metabolism Research have measured how well the learning of associations works in participants...

Several anti-obesity medications could be manufactured and profitability sold worldwide at far lower estimated lower prices compared to...